Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase γ

Molecular Pharmacology

Volumn 66, Issue 2, 2004, Pages 293-301

  Burelout, Chantal ^a   Thibault, Nathalie ^a   Levasseur, Sylvain ^a   Simard, Sébastien ^a   Naccache, Paul H ^b   Bourgoin, Sylvain G ^b,c  

^a Université Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GUANOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOLIPASE D; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN; PROTEIN KINASE C; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SUPEROXIDE; TYROSINE; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; CALCIUM; DRUG DERIVATIVE; ISOENZYME; METHIONYL LEUCYL PHENYLALANINE; METHIONYL-LEUCYL-PHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE GAMMA; PRKCA PROTEIN, HUMAN; PROSTAGLANDIN EP2 RECEPTOR; PROTEIN KINASE C ALPHA;

ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUTROPHIL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL MEMBRANE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADP-RIBOSYLATION FACTOR 1; CALCIUM; CELL MEMBRANE; DINOPROSTONE; HUMANS; ISOENZYMES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHOSPHOLIPASE D; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RECEPTORS, PROSTAGLANDIN E; RHO GTP-BINDING PROTEINS; TYROSINE;

EID: 3343006943     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.2.293     Document Type: Article

References (40)

1. Agwu DE, McCall CE, and McPhail LC (1991) Regulation of phospholipase D-induced hydrolysis of choline-containing phosphoglycerides by cyclic AMP in human neutrophils. J Immunol 146:3895-3903.
2. 2+ influx. J Biol Chem 270:23816-23822.
3. Armstrong RA (1995) Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 116:2903-2908.
4. Babior BM (1999) NADPH oxidase: an update. Blood 93:1464-1476.
5. Benard V, Bohl BP, and Bokoch GM (1999) Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 274:13198-13204.
6. Bloemen PG, van den Tweel MC, Henricks PA, Engels F, Kester MH, van de Loo PG, Blomjous FJ, and Nijkamp FP (1997) Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am J Physiol 272:L580-L587.
7. Breyer RM, Bagdassarian CK, Myers SA, and Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690.
8. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K, Schultz G, and Nurnberg B (2003) Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J Cell Biol 160:89-99.
9. Chimini G and Chavrier P (2000) Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2:E191-6.
10. Cockcroft S (2001) Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 58:1674-1687.
11. Corvera S and Czech MP (1998) Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol 8:442-446.
12. Exton JH (1999) Regulation of phospholipase D. Biochim Biophys Acta 1439:121-133.
13. Fantone JC and Kinnes DA (1983) Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 113:506-512.
14. Frohman MA, Sung TC, and Morris AJ (1999) Mammalian phospholipase D structure and regulation. Biochim Biophys Acta 1439:175-186.
15. Gilbert C, Levasseur S, Desaulniers P, Dusseault AA, Thibault N, Bourgoin SG, and Naccache PH (2003) Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. J Immunol 170:5235-5243.
16. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science (Wash DC) 279:509-514.
17. Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, and Kuehl FA Jr (1983) Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 80:4349-4353.
18. Hecker G, Ney P, and Schror K (1990) Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2. Naunyn Schmiedeberg's Arch Pharmacol 341:308-315.
19. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, and Wymann MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science (Wash DC) 287:1049-1053.
20. Houle MG, Kahn RA, Naccache PH, and Bourgoin S (1995) ADP-ribosylation factor translocation correlates with potentiation of GTPγS-stimulated phospholipase D activity in membrane fractions of HL-60 cells. J Biol Chem 270:22795-22800.
21. Houle MG, Naccache PH, and Bourgoin S (1999) Tyrosine kinase-regulated small GTPase translocation and the activation of phospholipase D in HL60 granulocytes. J Leukoc Biol 66:1021-1030.
22. 3CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 276:31831-31838.
23. Lachance G, Levasseur S, and Naccache PH (2002) Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidylinositol 3-kinases. J Biol Chem 277:21537-21541.
24. Laudanna C, Campbell JJ, and Butcher EC (1996) Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science (Wash DC) 271:981-983.
25. Lennartz MR (1999) Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis. Int J Biochem Cell Biol 31:415-430.
26. Liscovitch M, Czarny M, Fiucci G, and Tang X (2000) Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 345 Pt 3:401-415.
27. Marcil J, Harbour D, Houle MG, Naccache PH, and Bourgoin S (1999) Monosodium urate-crystal-stimulated phospholipase D in human neutrophils. Biochem J 337 (Pt 2):185-192.
28. Marcil J, Harbour D, Naccache PH, and Bourgoin S (1997) Human phospholipase D1 can be tyrosine-phosphorylated in HL-60 granulocytes. J Biol Chem 272:20660-20664.
29. Naccache PH, Levasseur S, Lachance G, Chakravarti S, Bourgoin SG, and McColl SR (2000) Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase γ. J Biol Chem 275:23636-23641.
30. Pai JK, Siegel MI, Egan RW, and Billah MM (1988) Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. J Biol Chem 263:12472-12477.
31. Reinhold SL, Prescott SM, Zimmerman GA, and McIntyre TM (1990) Activation of human neutrophil phospholipase D by three separable mechanisms. FASEB J 4:208-214.
32. Rivkin I, Rosenblatt J, and Becker EL (1975) The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J Immunol 115:1126-1134.
33. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, and Bourne HR (2000) Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science (Wash DC) 287:1037-1040.
34. Takenawa T, Ishitoya J, and Nagai Y (1986) Inhibitory effect of prostaglandin E2, forskolin and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea pig neutrophils. J Biol Chem 261:1092-1098.
35. Talpain E, Armstrong RA, Coleman RA, and Vardey CJ (1995) Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol 114:1459-1465.
36. Theron A, Steel H, Tintinger G, and Anderson R (2002) Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium. Inflamm Res 51:594-602.
37. Thibault N, Harbour D, Borgeat P, Naccache PH, and Bourgoin SG (2000) Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases. Blood 95:519-527.
38. Tilley SL, Coffman TM, and Koller BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Investig 108:15-23.
39. Vlahos CJ, Matter WF, Brown RF, Traynor-Kaplan AE, Heyworth PG, Prossnitz ER, Ye RD, Marder P, Schelm JA, Rothfuss KJ, et al. (1995) Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J Immunol 154:2413-2422.
40. Welch HC, Coadwell WJ, Stephens LR, and Hawkins PT (2003) Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546:93-97.